Amgen: Amgen to spend $900M to expand U.S. biopharma manufacturing

Amgen announced that it plans to invest $900 million to expand its pharmaceutical manufacturing facility in Ohio. The expansion brings the total number of jobs created to 750. Amgen's total investment in Central Ohio now eclipses $1.4 billion. "Amgen has been a leading U.S.-based manufacturer of biologic medicines since 1988. Today's investment reinforces our ongoing...The post Amgen to spend $900M to expand U.S. biopharma manufacturing appeared first on Pharmaceutical Processing World.